Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies

14 July 2010 Philadelphia, PA Past Event

Location

Union League
Philadelphia, PA

Agenda

July 14-15, 2010

David Rosen will present, "Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies" at the ACI 7th National Forum on Off-Label Communications, July 14-15, 2010 at the Union League, in Philadelphia.

Speakers will cover compliance strategies with FDA off-label promotion guidelines, training physicians on the use of medical devices, and learning from device manufacturers' litigation. Thomas Lynch, Senior Corporate Counsel at Boston Scientific will join Mr. Rosen as a speaker.

More information can be found on ACI's Web site.

Related Services

Insights

Lacktman, Ferrante Cited in mHealth Intelligence About Ryan Haight Act
19 September 2019
mHealth Intelligence
Vernaglia Comments on AHA v Azar Decision
18 September 2019
MedPage Today
Tinnen Discusses How Viewpoint Diversity Helps Businesses Thrive
18 September 2019
InsideTrack
Lach Comments on Launch of New Group
16 September 2019
BizTimes Milwaukee
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.

Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies

Location

Union League
Philadelphia, PA

Agenda

July 14-15, 2010